Search

for
Search:

Research

5 / 1000+ results

research Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review

5 citations , January 2020 in “Skin appendage disorders”

This study found that oral dutasteride increased hair count more than intralesional administration in androgenetic alopecia, but more research is needed for a reliable comparison.

research Effectiveness and Safety of Intralesional Dutasteride in Patients With Androgenic Alopecia: A Systematic Review and Meta‐Analysis

December 2025 in “Journal of Cosmetic Dermatology”

This systematic review found that intralesional dutasteride treatments for androgenic alopecia in adults improved hair density and thickness with minimal adverse effects, although study methodologies varied and lacked large-scale trials.

research Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients

2 citations , March 2022 in “Journal of The European Academy of Dermatology and Venereology”

This letter to the editor presents no new research results; it discusses a combination of dutasteride intralesional microinjections with oral minoxidil versus oral minoxidil alone for treating androgenetic alopecia in men.

research Treatment of intralesional corticoisteroid-induced cutaneous atrophy with hyaluronic acid filling

1 citations , July 2018 in “Journal of dermatology & cosmetology”

This case report describes a treatment approach for frontal and temporal alopecia using oral dutasteride, minoxidil lotion, and triamcinolone injections, with hyaluronic acid successfully treating injection site atrophy.

research A clinical trial on the efficacy of mesotherapy with dutasteride for frontal fibrosing alopecia

August 2024 in “JEADV Clinical Practice”

In this clinical trial, 16 women with frontal fibrosing alopecia experienced significant improvements in hair density, vellus hair count, and quality of life after monthly intralesional dutasteride treatments, though larger and longer-term studies are needed to confirm these findings.

View more "intralesional dutasteride" in research →

Community Join

5 / 1000+ results

community Dutasteride Mesotherapy instead of topical or pills

8 upvotes 5 days ago

Dutasteride Mesotherapy is discussed as a method to target scalp DHT suppression with minimal systemic absorption. It is considered less effective than oral treatments.

community Dutasteride mesotherapy to lower dut dose

in Finasteride/Dutasteride 1 upvotes 1 year ago

The conversation is about a user considering reducing their dutasteride dose due to side effects like lower libido and watery semen. They plan to use dutasteride mesotherapy every three months to maintain hair while reducing systemic DHT suppression.

community thoughts on dutasteride mesotherapy?

3 upvotes 3 years ago

Dutasteride mesotherapy for hair loss, with the user reporting minimal pain during the procedure. Other users mention success stories and inquire about additional treatments.

community Dutasteride mesotherapy alongside oral fin and dut?

2 upvotes 8 months ago

Dutasteride mesotherapy, combined with peptides and exosomes, is being considered for hair loss treatment. One user suggests that oral finasteride or dutasteride mesotherapy may not be necessary if already taking oral dutasteride.

community Switching from oral to topical dut

in Finasteride/Dutasteride 1 upvotes 7 months ago

Switching from oral to topical dutasteride can cause shedding due to changes in DHT levels, and it's recommended to overlap both treatments to minimize this effect. Topical dutasteride may cause scalp irritation, and the user is considering dutasteride mesotherapy as an alternative.

View more "intralesional dutasteride" in community →

Learn

1 / 800 results

learn Dutasteride

5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

Will I notice changes in my body if I start taking dutasteride? Dutasteride lowers DHT, so labels and trials describe prostate shrinkage over 3-6 months and, off-label, slowed hair loss; the same sources list sexual side effects that may persist after stopping, breast and semen changes, rare allergic reactions, and an observational link to depression.
Dutasteride: Correct Dosage and Administration The US label dose of dutasteride (for BPH) is 0.5 mg once daily; in Japan the approved hair-loss dose is 0.1 mg daily, increased to 0.5 mg if needed. Any dose or schedule for hair loss should be set by a prescriber.
Dutasteride side effects: what the label and studies actually report The Avodart label reports impotence in 4.7% and decreased libido in 3.0% of men in the first six months (1.7% and 1.4% on placebo), with new reports falling after month six; those figures come from BPH trials in older men, and the hair-loss trials in younger men run only six months. The label and studies also flag a PSA drop of about half, a small rise in high-grade prostate cancer in one trial, an observational link to depression, and sexual effects that the label says may persist after stopping.
All 5 questions on Dutasteride →

View more "intralesional dutasteride" in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →